Author of the article:
JERUSALEM — Israel has ordered 100,000 units of Pfizer Inc’s anti-viral COVID 19 pill Paxlovid for people aged 12 and older at risk of severe illness, an Israeli official said on Saturday, confirming a television report.
Channel 12 TV said Israeli Prime Minister Naftali Bennett agreed the deal in a phone conversation with Pfizer CEO Albert Bourla. There was no immediate confirmation from the company.
The first oral and at home treatment for COVID-19, Paxlovid was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from Pfizer’s clinical trial. Recent lab data suggests the drug retains effectiveness against the Omicron variant, it said. (Writing by Dan Williams; Editing by Andrew Cawthorne)
Advertisement
This advertisement has not loaded yet, but your article continues below.
Financial Post Top Stories
Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.
By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300